References
- Noseworthy JH, Lucchinetti C, Rodriguez M, Multiple sclerosis. N Engl J Med 2000;343:938–52.
- Tan ZY, Bealgey KW, Fang Y, Interleukin-23: immunological roles and clinical implications. Int J Biochem Cell Biol 2009;41:733–5.
- Iwakura Y, Ishigame H. The IL-23/IL-17 axis in inflammation. J Clin Invest 2006;116:1218–22.
- Parham C, Chirica M, Timans J, A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol 2002; 168:5699–708.
- Duerr RH, Taylor KD, Brant SR, A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006;314:1461–3.
- Glas J, Seiderer J, Wagner J, Analysis of IL12B gene variants in inflammatory bowel disease. PLoS One 2012;7:e34349.
- Cargill M, Schrodi SJ, Chang M, A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 2007; 80:273–90.
- Capon F, Di Meglio P, Szaub J, Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum Genet 2007;122:201–206.
- Karaderi T, Harvey D, Farrar C, Association between the interleukin 23 receptor and ankylosing spondylitis is confirmed by a new UK case-control study and meta-analysis of published series. Rheumatology (Oxford) 2009;48:386–9.
- Wong RH, Wei JC, Huang CH, Association of IL-12B genetic polymorphism with the susceptibility and disease severity of ankylosing spondylitis. J Rheumatol 2012;39:135–40.
- van Veen T, Crusius JBA, Schrijver HM, Interleukin-12p40 genotype plays a role in the susceptibility to multiple sclerosis. Ann Neurol 2001;50:275.
- Alloza I, Heggarty S, Goris A, Interleukin-12 p40 polymorphism and susceptibility to multiple sclerosis. Ann Neurol 2002;52:524–5.
- Illes Z, Safrany E, Peterfalvi A, 3'UTR C2370A allele of the IL-23 receptor gene is associated with relapsing-remitting multiple sclerosis. Neurosci Lett 2008;431:36–8.
- Núñez C, Dema B, Cénit MC, IL23R: a susceptibility locus for celiac disease and multiple sclerosis? Genes Immun. 2008; 9:289–93.
- Roos IM, Kockum I, Hillert J. The interleukin 23 receptor gene in multiple sclerosis: a case-control study. J Neuroimmunol 2008;194:173–80.
- Hall MA, McGlinn E, Coakley G, Genetic polymorphism of IL-12 p40 gene in immune-mediated disease. Genes Immun 2000;1:219–24.
- Begovich AB, Chang M, Caillier SJ, The autoimmune disease-associated IL12B and IL23R polymorphisms in multiple sclerosis. Hum Immunol 2007;68:934–7.
- Forte GI, Ragonese P, Salemi G, Search for genetic factors associated with susceptibility to multiple sclerosis. Ann N Y Acad Sci 2006;1067:264–9.
- McDonald WI, Compston A, Edan G, Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121–7.
- Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444–52.
- Huber AK, Jacobson EM, Jazdzewski K, Interleukin(IL)-23 receptor is a major susceptibility gene for Graves'ophthalmopathy: the IL-23/T-helper 17 axis extends to thyroid autoimmunity. J Clin Endocrinol Metab 2008;93:1077–81.
- Lincoln MR, Montpetit A, Cader MZ, A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat Genet 2005;37:1108–12.
- Burton PR, Clayton DG, Cardon LR, Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007;39:1329–37.
- International Multiple Sclerosis Genetics Conssortium (IMSGC). IL12A, PHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci. Genes Immun 2010;11:397–405.
- Sawcer S, Hellenthal G, Pirinen M, Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011;476:214–9.